Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Intervention and Therapeutics
Published in: Cardiovascular Intervention and Therapeutics 2/2020

Open Access 01-04-2020 | Angiography | Expert Consensus Document

Clinical expert consensus document on quantitative coronary angiography from the Japanese Association of Cardiovascular Intervention and Therapeutics

Authors: Nobuaki Suzuki, Taku Asano, Gaku Nakazawa, Jiro Aoki, Kengo Tanabe, Kiyoshi Hibi, Yuji Ikari, Ken Kozuma

Published in: Cardiovascular Intervention and Therapeutics | Issue 2/2020

Login to get access

Abstract

Quantitative coronary angiography (QCA) remains to play an important role in clinical trials and post-marketing surveillance related to the safety and efficacy of new PCI devices. In this document, the current standard methodology of QCA is summarized. In addition, its history, recent development and future perspectives are also reviewed.
Literature
1.
Byrne RA, Serruys PW, Baumbach A, Escaned J, Fajadet J, James S, et al. Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary. Eur Heart J. 2015;36:2608–20.PubMed
2.
Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, et al. Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 Consensus Document. Circulation. 2018;137:2635–50.PubMed
3.
Farb A, Zuckerman BD. Clinical event adjudication in cardiovascular device trials: an Food and Drug Administration perspective. Am Heart J. 2017;191:62–4.PubMed
4.
West JW, Guzman SV. Coronary dilatation and constriction visualized by selective arteriography. Circ Res. 1959;7:527–36.PubMed
5.
Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975;51:5–40.PubMed
6.
Zir LM, Miller SW, Dinsmore RE, Gilbert JP, Harthorne JW. Interobserver variability in coronary angiography. Circulation. 1976;53:627–32.PubMed
7.
Gensini GG, Kelly AE, Da Costa BC, Huntington PP. Quantitative angiography: the measurement of coronary vasomobility in the intact animal and man. Chest. 1971;60:522–30.PubMed
8.
Brown BG, Bolson E, Frimer M, Dodge HT. Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation. Circulation. 1977;55:329–37.PubMed
9.
Serruys PW, Reiber JH, Wijns W, van den Brand M, Kooijman CJ, ten Katen HJ, et al. Assessment of percutaneous transluminal coronary angioplasty by quantitative coronary angiography: diameter versus densitometric area measurements. Am J Cardiol. 1984;54:482–8.PubMed
10.
Kondo H, Ito S, Shigeyama J, Ito O, Matsushita T, Okamoto M, et al. Beneficial application of quantitative coronary angiography (edge detection algorithm) in analysis of dissected coronary arteries to predict long-term patency. Jpn Circ J. 2000;64:667–71.PubMed
11.
Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331:489–95.PubMed
12.
Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: 1-year angiographic and intravascular ultrasound follow-up. Circulation. 2001;104:2007–11.PubMed
13.
Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med. 1996;334:561–6.PubMed
14.
Tsuchikane E, Fukuhara A, Kobayashi T, Kirino M, Yamasaki K, Izumi M, et al. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Circulation. 1999;100:21–6.PubMed
15.
Tsuchikane E, Sumitsuji S, Awata N, Nakamura T, Kobayashi T, Izumi M, et al. Final results of the STent versus directional coronary Atherectomy Randomized Trial (START). J Am Coll Cardiol. 1999;34:1050–7.PubMed
16.
Suzuki T, Hosokawa H, Katoh O, Fujita T, Ueno K, Takase S, et al. Effects of adjunctive balloon angioplasty after intravascular ultrasound-guided optimal directional coronary atherectomy: the result of Adjunctive Balloon Angioplasty After Coronary Atherectomy Study (ABACAS). J Am Coll Cardiol. 1999;34:1028–35.PubMed
17.
Kozuma K, Hara K, Yamasaki M, Morino Y, Ayabe S, Kuroda Y, et al. Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz–Schatz coronary stent implantation. Am Heart J. 2001;141:124–30.PubMed
18.
Nasu K, Tsuchikane E, Awata N, Matsumoto H, Shiota A, Takeda Y, et al. Quantitative angiographic and intravascular ultrasound study > 5 years after directional coronary atherectomy. Am J Cardiol. 2004;93:543–8.PubMed
19.
Ikari Y, Sakurada M, Kozuma K, Kawano S, Katsuki T, Kimura K, et al. Upfront thrombus aspiration in primary coronary intervention for patients with ST-segment elevation acute myocardial infarction: report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) trial. JACC Cardiovasc Interv. 2008;1:424–31.PubMed
20.
Tsuchikane E, Suzuki T, Asakura Y, Oda H, Ueda K, Tanaka T, et al. Debulking of chronic coronary total occlusions with rotational or directional atherectomy before stenting: final results of DOCTORS study. Int J Cardiol. 2008;125:397–403.PubMed
21.
Kimura T, Morimoto T, Natsuaki M, Shiomi H, Igarashi K, Kadota K, et al. Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the randomized evaluation of sirolimus-eluting versus everolimus-eluting stent trial (RESET). Circulation. 2012;126:1225–36.PubMed
22.
Habara S, Iwabuchi M, Inoue N, Nakamura S, Asano R, Nanto S, et al. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J. 2013;166:527–33.PubMed
23.
Natsuaki M, Kozuma K, Morimoto T, Kadota K, Muramatsu T, Nakagawa Y, et al. Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial. J Am Coll Cardiol. 2013;62:181–90.PubMed
24.
Natsuaki M, Kozuma K, Morimoto T, Shiomi H, Kimura T. Two-year outcome of a randomized trial comparing second-generation drug-eluting stents using biodegradable or durable polymer. JAMA. 2014;311:2125–7.PubMed
25.
Kimura T, Kozuma K, Tanabe K, Nakamura S, Yamane M, Muramatsu T, et al. A randomized trial evaluating everolimus-eluting absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J. 2015;36:3332–42.PubMed
26.
Ikari Y, Kyono H, Isshiki T, Ishizuka S, Nasu K, Sano K, et al. Usefulness of everolimus-eluting coronary stent implantation in patients on maintenance hemodialysis. Am J Cardiol. 2015;116:872–6.PubMed
27.
Morino Y, Tobaru T, Yasuda S, Kataoka K, Tanabe K, Hirohata A, et al. Biodegradable polymer-based, argatroban-eluting, cobalt–chromium stent (JF-04) for treatment of native coronary lesions: final results of the first-in-man study and lessons learned. Eurointervention. 2016;12:1271–8.PubMed
28.
Suzuki K, Ishikawa T, Mutoh M, Sakamoto H, Kubota T, Ogawa T, et al. Midterm angiographic outcomes with sirolimus- and everolimus-eluting stents for small vessels in diabetic patients: propensity-score-matched comparisons in three different vessel diameters. Cardiovasc Interv Ther. 2018;33:205–16.PubMed
29.
Saito S, Krucoff MW, Nakamura S, Mehran R, Maehara A, Al-Khalidi HR, et al. Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich’s Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome. Eur Heart J. 2018;39:2460–8.PubMedPubMedCentral
30.
Saito S, Ando K, Ito Y, Tobaru T, Yajima J, Kimura T, et al. Two-year results after coronary stenting of small vessels in Japanese population using 2.25-mm diameter sirolimus-eluting stent with bioresorbable polymer: primary and long-term outcomes of CENTURY JSV study. Cardiovasc Interv Ther. 2019;34:25–33.PubMed
31.
Aoki J, Nakazawa G, Ando K, Nakamura S, Tobaru T, Sakurada M, et al. Effect of combination of non-slip element balloon and drug-coating balloon for in-stent restenosis lesions (ELEGANT study). J Cardiol. 2019;74:436–42.PubMed
32.
Onishi T, Onishi Y, Kobayashi I, Umezawa S, Niwa A. Drug-coated balloon angioplasty for de novo small vessel disease including chronic total occlusion and bifurcation in real-world clinical practice. Cardiovasc Interv Ther. 2019;34:139–48.PubMed
33.
34.
Matsuo H, Kawase Y. FFR and iFR guided percutaneous coronary intervention. Cardiovasc Interv Ther. 2016;31:183–95.PubMed
35.
Kawase Y, Matsuo H, Akasaka T, Shiono Y, Tanaka N, Amano T, et al. Clinical use of physiological lesion assessment using pressure guidewires: an expert consensus document of the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther. 2019;34:85–96.PubMed
36.
Saito T, Misaki M, Shirato K, Takishima T. Three-dimensional quantitative coronary angiography. IEEE Trans Biomed Eng. 1990;37:768–77.PubMed
37.
Nishi T, Kitahara H, Fujimoto Y, Nakayama T, Sugimoto K, Takahara M, et al. Comparison of 3-dimensional and 2-dimensional quantitative coronary angiography and intravascular ultrasound for functional assessment of coronary lesions. J Cardiol. 2017;69:280–6.PubMed
38.
Tu S, Westra J, Yang J, von Birgelen C, Ferrara A, Pellicano M, et al. Diagnostic accuracy of fast computational approaches to derive fractional flow reserve from diagnostic coronary angiography: the International Multicenter FAVOR Pilot Study. JACC Cardiovasc Interv. 2016;9:2024–35.PubMed
39.
Wunderlich W, Fischer F, Linderer T, Kirkeeide RL. Analytic isocenter calibration. A new approach for accurate X-ray gantries. Angiology. 1995;46:577–82.PubMed
40.
Hess OM, Buchi M, Kirkeeide RL, Muser M, Osenberg H, Niederer P, et al. Quantitative coronary arteriography at rest and during exercise. In: Reiber JHC, Serruys PW, editors. Quantitative coronary arteriography. Dordrecht: Springer; 1991. p. 145–53.
41.
Tomkowiak MT, Speidel MA, Raval AN, Van Lysel MS. Calibration-free device sizing using an inverse geometry X-ray system. Med Phys. 2011;38:283–93.PubMed
42.
Ito S, Kinoshita K, Endo A, Nakamura M, Muramatsu T. Impact of catheter size on reliability of quantitative coronary angiographic measurements (comparison of 4Fr and 6Fr catheters). Heart Vessels. 2016;31:1752–7.PubMed
43.
Tadehara F, Imazu M, Kono S, Sano K. Calibration with currently available low-radiopacity catheters for scaling in digital quantitative coronary angiography. Investig Radiol. 2001;36:705–12.
44.
Sabate M, Costa MA, Kozuma K, Kay IP, van der Giessen WJ, Coen VL, et al. Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation. 2000;101:2467–71.PubMed
45.
Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–23.PubMed
46.
Pocock SJ, Lansky AJ, Mehran R, Popma JJ, Fahy MP, Na Y, et al. Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol. 2008;51:23–32.PubMed
47.
Ito S, Kinoshita K, Endo A, Nakamura M. Impact of cine frame selection on quantitative coronary angiography results. Clin Med Insights Cardiol. 2019;13:1179546819838232.PubMedPubMedCentral
48.
Kozuma K, Kashiwabara K, Shinozaki T, Oba K, Matsuyama Y. Two-by-two cross-over study to evaluate agreement between versions of a quantitative coronary analysis system (QAngio XA). Int J Cardiovasc Imaging. 2017;33:779–87.PubMed
49.
Kubo T, Akasaka T, Shite J, Suzuki T, Uemura S, Yu B, et al. OCT compared with IVUS in a coronary lesion assessment: the OPUS-CLASS study. JACC Cardiovasc Imaging. 2013;6:1095–104.PubMed
50.
Sotomi Y, Onuma Y, Miyazaki Y, Asano T, Katagiri Y, Tenekecioglu E, et al. Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt–chromium metallic stent? Eurointervention. 2017;13:e585–94.PubMed
51.
Costa MA, Sabate M, Angiolillo DJ, Hu P, Jimenez-Quevedo P, Corros C, et al. Relocation of minimal luminal diameter after bare metal and drug-eluting stent implantation: incidence and impact on angiographic late loss. Catheter Cardiovasc Interv. 2007;69:181–8.PubMed
52.
Huo Y, Finet G, Lefevre T, Louvard Y, Moussa I, Kassab GS. Optimal diameter of diseased bifurcation segment: a practical rule for percutaneous coronary intervention. Eurointervention. 2012;7:1310–6.PubMed
53.
Lansky A, Tuinenburg J, Costa M, Maeng M, Koning G, Popma J, et al. Quantitative angiographic methods for bifurcation lesions: a consensus statement from the European Bifurcation Group. Catheter Cardiovasc Interv. 2009;73:258–66.PubMed
54.
Ishibashi Y, Grundeken MJ, Nakatani S, Iqbal J, Morel MA, Genereux P, et al. In vitro validation and comparison of different software packages or algorithms for coronary bifurcation analysis using calibrated phantoms: implications for clinical practice and research of bifurcation stenting. Catheter Cardiovasc Interv. 2015;85:554–63.PubMed
55.
Girasis C, Onuma Y, Schuurbiers JC, Morel MA, van Es GA, van Geuns RJ, et al. Validity and variability in visual assessment of stenosis severity in phantom bifurcation lesions: a survey in experts during the fifth meeting of the European Bifurcation Club. Catheter Cardiovasc Interv. 2012;79:361–8.PubMed
56.
Di Mario C, Sutaria N. Coronary angiography in the angioplasty era: projections with a meaning. Heart. 2005;91:968–76.PubMedPubMedCentral
57.
Klein JL, Hoff JG, Peifer JW, Folks R, Cooke CD, King SB 3rd, et al. A quantitative evaluation of the three dimensional reconstruction of patients’ coronary arteries. Int J Card Imaging. 1998;14:75–87.PubMed
58.
Dvir D, Marom H, Guetta V, Kornowski R. Three-dimensional coronary reconstruction from routine single-plane coronary angiograms: in vivo quantitative validation. Int J Cardiovasc Intervent. 2005;7:141–5.PubMed
59.
Yong AS, Ng AC, Brieger D, Lowe HC, Ng MK, Kritharides L. Three-dimensional and two-dimensional quantitative coronary angiography, and their prediction of reduced fractional flow reserve. Eur Heart J. 2011;32:345–53.PubMed
60.
Onuma Y, Girasis C, Aben JP, Sarno G, Piazza N, Lokkerbol C, et al. A novel dedicated 3-dimensional quantitative coronary analysis methodology for bifurcation lesions. Eurointervention. 2011;7:629–35.PubMed
61.
Girasis C, Schuurbiers JC, Muramatsu T, Aben JP, Onuma Y, Soekhradj S, et al. Advanced three-dimensional quantitative coronary angiographic assessment of bifurcation lesions: methodology and phantom validation. Eurointervention. 2013;8:1451–60.PubMed
62.
Group TS. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312:932–6.
63.
Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93:879–88.PubMed
64.
Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000;101:125–30.PubMed
65.
Ross AM, Neuhaus KL, Ellis SG. Frequent lack of correspondence among core laboratories in assessing TIMI flow grade after reperfusion therapy. Circulation. 1995;92:I–345.
66.
Tanedo JS, Kelly RF, Marquez M, Burns DE, Klein LW, Costanzo MR, et al. Assessing coronary blood flow dynamics with the TIMI frame count method: comparison with simultaneous intracoronary Doppler and ultrasound. Catheter Cardiovasc Interv. 2001;53:459–63.PubMed
67.
Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993;87:1354–67.PubMed
68.
De Bruyne B, Baudhuin T, Melin JA, Pijls NH, Sys SU, Bol A, et al. Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation. 1994;89:1013–22.PubMed
69.
Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, vant’t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213–24.PubMed
70.
De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367:991–1001.PubMed
71.
Morris PD, Ryan D, Morton AC, Lycett R, Lawford PV, Hose DR, et al. Virtual fractional flow reserve from coronary angiography: modeling the significance of coronary lesions: results from the VIRTU-1 (VIRTUal Fractional Flow Reserve From Coronary Angiography) study. JACC Cardiovasc Interv. 2013;6:149–57.PubMed
72.
Papafaklis MI, Muramatsu T, Ishibashi Y, Lakkas LS, Nakatani S, Bourantas CV, et al. Fast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire—fractional flow reserve. Eurointervention. 2014;10:574–83.PubMed
73.
Collet C, Onuma Y, Sonck J, Asano T, Vandeloo B, Kornowski R, et al. Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis. Eur Heart J. 2018;39:3314–21.PubMed
74.
Sejr-Hansen M, Westra J, Thim T, Christiansen EH, Eftekhari A, Kristensen SD, et al. Quantitative flow ratio for immediate assessment of nonculprit lesions in patients with ST-segment elevation myocardial infarction-An iSTEMI substudy. Catheter Cardiovasc Interv. 2019;94:686–92.PubMed
75.
Kogame N, Takahashi K, Tomaniak M, Chichareon P, Modolo R, Chang CC, et al. Clinical implication of quantitative flow ratio after percutaneous coronary intervention for 3-vessel disease. JACC Cardiovasc Interv. 2019;12:2064–75.PubMed
76.
Asano T, Katagiri Y, Chang CC, Kogame N, Chichareon P, Takahashi K, et al. Angiography-derived fractional flow reserve in the SYNTAX II trial: feasibility, diagnostic performance of quantitative flow ratio, and clinical prognostic value of functional SYNTAX score derived from quantitative flow ratio in patients with 3-vessel disease. JACC Cardiovasc Interv. 2019;12:259–70.PubMed
77.
78.
Hamaya R, Hoshino M, Kanno Y, Yamaguchi M, Ohya H, Sumino Y, et al. Prognostic implication of three-vessel contrast-flow quantitative flow ratio in patients with stable coronary artery disease. Eurointervention. 2019;15:180–8.PubMed
79.
Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, et al. Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy. Eurointervention. 2018;14:e570–9.PubMed
80.
Asano T, Serruys PW, Collet C, Miyazaki Y, Takahashi K, Chichareon P, et al. Angiographic late lumen loss revisited: impact on long-term target lesion revascularization. Eur Heart J. 2018;39:3381–9.PubMed
81.
Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974;33:87–94.PubMed
Metadata
Title
Clinical expert consensus document on quantitative coronary angiography from the Japanese Association of Cardiovascular Intervention and Therapeutics
Authors
Nobuaki Suzuki
Taku Asano
Gaku Nakazawa
Jiro Aoki
Kengo Tanabe
Kiyoshi Hibi
Yuji Ikari
Ken Kozuma
Publication date
01-04-2020
Publisher
Springer Japan
Published in
Cardiovascular Intervention and Therapeutics / Issue 2/2020
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-020-00653-7

Other articles of this Issue 2/2020

Cardiovascular Intervention and Therapeutics 2/2020 Go to the issue

Original Article

Guide catheter extension lock enables the strongest backup force during the antegrade approach in percutaneous coronary intervention

Original Article

Delirium is associated with higher mortality in transcatheter aortic valve replacement: systemic review and meta-analysis

Original Article

Post-occlusional hyperemia for fractional flow reserve assessment and pull-back curve analysis

Original Article

A prospective interventional registry of short-term dual-antiplatelet treatment after implantation of drug-eluting stents in patients with atrial fibrillation requiring oral anticoagulation therapy

Original Article

Long-term outcomes of three-vessel coronary artery disease after coronary revascularization by percutaneous coronary intervention using second-generation drug-eluting stents versus coronary artery bypass graft surgery

Images in Cardiovascular Intervention

Life-threatening acute coronary obstruction caused by the commissure of a Sapien 3 prosthesis during transcatheter aortic valve implantation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits